A PROSPECTIVE OPEN LABEL SINGLE ARM STUDY ON THE EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN REDUCING THE ABNORMAL INVOLUNTARY MOVEMENTS OF ANTIPSYCHOTIC INDUCED TARDIVE DYSKINESIA

This prospective open label single arm study evaluates the effectiveness of Homoeopathic Medicines in reducing the abnormal involuntary movements of anti psychotic induced Tardive Dyskinesia using Abnormal Involuntary Movement Scale(AIMS) Secondary objective include assessing improvements in quality of life of patient through WHO-QOL BREF scale .Patients will be recruited from the Out patient Department(OPD),In patient Department(IPD),and Peripheral Centres of the National Homoeopathic Research Institute in Mental Health (NHRIMH), Kottayam, following screening based on Verbal Screening Questioner Enrolment requires psychiatric confirmation ,and informed consent/Assent will be obtained from legally authorised representative in English and Malayalam .Baseline assessment include AIMS for severity, with evaluations conducted monthly and tri-monthly, respectively ,while quality of lifewillbemonitoredusingtheWHO-QOLBREFscale.Adetailedcasehistoryandoneon the case recording format and indicated Homoeopathic remedies will be prescribed based on repertorization via RADAR OPUS software and in comparison with Homoeopathic Materia Medica. Patients missing follow-ups for three consecutive months will be considered dropouts and will receive standard  OPD care but will be excluded from further study evaluation. The study aims to provide effectiveness of Homoeopathy’s role as an adjuvant therapy in Tardive Dyskinesia, assessing its ability to improve symptoms and enhance the quality of life